Castillo AB, Triplett JW, Pavalko FM, Turner CH. Estrogen receptor-␤ regulates mechanical signaling in primary osteoblasts. Am J Physiol Endocrinol Metab 306: E937-E944, 2014. First published March 11, 2014; doi:10.1152/ajpendo.00458.2013.-Mechanical loading is an important regulator in skeletal growth, maintenance, and aging. Estrogen receptors have a regulatory role in mechanically induced bone adaptation. Estrogen receptor-␣ (ER␣) is known to enhance load-induced bone formation, whereas ER␤ negatively regulates this process. We hypothesized that ER␤ regulates mechanical signaling in osteoblasts. We tested this hypothesis by subjecting primary calvarial cells isolated from wild-type and ER␤-knockout mice (BERKO) to oscillatory fluid flow in the absence or presence of estradiol (E 2). We found that the known responses to fluid shear stress, i.e., phosphorylation of the mitogen-activated protein kinase ERK and upregulation of COX-2 expression, were inhibited in BERKO cells in the absence of E2. Flow-induced increase in prostaglandin E2 (PGE2) release was not altered in BERKO cells in the absence of E2, but was increased when E2 was present. Additionally, immunofluorescence analysis and estrogen response element luciferase assays revealed increased ER␣ expression and flow-and ligand-induced nuclear translocation as well as transcriptional activity in BERKO cells in both the presence and absence of E 2. Taken together, these data suggest that ER␤ plays both ligand-dependent and ligand-independent roles in mechanical signaling in osteoblasts. Furthermore, our data suggest that one mechanism by which ER␤ regulates mechanotransduction in osteoblasts may result from its inhibitory effect on ER␣ expression and function. Targeting estrogen receptors (e.g., inhibiting ER␤) may represent an effective approach for prevention and treatment of age-related bone loss. estrogen receptor-␤; osteoblast; mechanobiology; cyclooxygenase-2; prostaglandin E 2 MECHANICAL LOADING IS AN IMPORTANT REGULATOR in skeletal growth, maintenance, and aging (25, 41, 47) . Increased bone formation is observed typically with increased mechanical loading, whereas bone loss is observed with decreased mechanical loading or disuse (27, 48) . Current evidence suggests that mechanical stress is sensed by osteocytes, which then signal osteoblasts and osteoclasts to either add or remove bone, respectively (5). The mechanism by which a physical stimulus is transformed into a biochemical signal, termed mechanotransduction, remains unclear (6).
estrogen levels increase in girls, periosteal expansion is inhibited (44) . Conversely, at the onset of menopause, when estrogen levels fall in women, radial expansion recommences, suggesting that estrogen inhibits periosteal bone apposition (19) . Estrogen also appears to inhibit exercise-induced periosteal expansion (4, 25) .
The mechanism for opposing effects of estrogen on bone formation appears to be related to signaling through distinct receptor isoforms. Estrogen signals via two receptors, estrogen receptor (ER)␣ and ER␤, which are members of the superfamily of ligand-regulated nuclear receptors (20) . The amino acid sequence homology between the two receptors is ϳ97% in the DNA-binding domain and ϳ56% in the ligand-binding domain. Ligand binding induces a conformational change, receptor dimerization, and translocation to the nucleus, where the activated receptor complex binds to DNA and recruits coregulator proteins to affect gene transcription. ERs can activate transcription by binding directly to DNA at the classical estrogen response element (ERE) or indirectly through interactions with the Jun/Fos family of transcription factors, which bind at activator protein-1 (AP-1) genomic elements (26) . Transcriptional activity of ER␣ and ER␤ is mediated by two transcription activation functions (AF), AF-1 and AF-2, that can exhibit differential activity levels, depending on the ligand, receptor type, and enhancer element combination (37) . ER␤ has been shown to reverse or inhibit ER␣ activation at AP-1 sites, suggesting that ER␤ has an overall suppressive action on transcription of certain genes modulated by ER␣ (30) .
ER␣ and ER␤ are expressed in human, rat, and mouse osteoblasts and osteocytes (8, 36) . Damien et al. (12) showed that a selective estrogen receptor modulator and ICI-182,780, a pure ER antagonist, inhibit the proliferative response of osteoblasts to strain and estrogen. In addition, they showed that mechanical strain results in the phosphorylation of ER␣, which is dependent on the phosphorylation of extracellular signalregulated kinase (ERK), a member of the mitogen-activated protein kinase (MAPK) family that is important in cell proliferation, differentiation, and apoptosis (21) . Both strain and estrogen result in a pronounced translocation of ER␣ from the cytoplasm to the nucleus in osteoblasts and osteocytes (56) . In addition, both strain and estrogen result in an increase in ER transcriptional activity, as measured by an ERE luciferase activity assay (55) , providing further evidence for a role for ERs in mechanical signaling in osteoblasts.
The specific role of each ER isoform in mechanically induced bone adaptation has been implicated in studies using ER-knockout mice. Lee et al. (28) showed that strain-induced periosteal bone formation was almost completely absent in ER␣-knockout (ERKO) mice. Conversely, similar studies in female ER␤ knockout (BERKO) mice exhibited an enhanced load-induced response suggesting that signaling via ER␤ normally suppresses periosteal bone formation (42, 43) . These findings were supported by in vitro studies in which primary long bone osteoblasts isolated from ERKO mice exhibited no strain-related increase in proliferation, whereas osteoblasts isolated from BERKO mice exhibited a 125% increase in cell number following mechanical strain (29) . Finally, Galea et al. (18) has provided evidence that both strain and estrogen work through ER␤ to downregulate Sost expression, which in turn enhances osteogenic activity (49a). Taken together, these data suggest that both ER␣ and ER␤ can regulate mechanical signaling in bone and influence bone adaptation and that the ER␤ itself or signaling via ER␤ may normally oppose mechanical signaling via ER␣ in osteoblasts.
The aim of this work was to further elucidate mechanisms by which ER␤ regulates osteoblast function in response to mechanical stimulation. We isolated primary calvarial cells from wild-type (WT) and BERKO neonates and subjected them to oscillatory fluid flow (OFF) for varying periods in the absence and presence of estradiol (E 2 ) and evaluated ERK, cyclooxygenase-2 (COX-2), and prostaglandin (PGE 2 ) signaling as well as expression of receptor levels and ER transcriptional activity.
MATERIALS AND METHODS
Cell culture. All experimental procedures involving primary mouse osteoblasts were approved by the Indiana University School of Medicine Institutional Animal Care and Use Committee. Primary mouse calvarial cells were isolated as described previously (54) . Briefly, calvaria from 3-to 5-day-old WT and BERKO mice (14) were isolated aseptically and exposed to seven consecutive 10-min digestions in 0.2% collagenase-0.25% trypsin. Cells released in the second through seventh digestions were pooled and maintained in phenol red-free Dulbecco's minimum essential medium (DMEM) supplemented with 10% fetal calf serum (FCS), 4 mM L-glutamine, and 1% penicillin-streptomycin antibiotics (Gibco-Invitrogen, Carlsbad, CA). At 80 -90% confluence, cells were passaged by brief trypsinization, with the medium changed every day. The osteoblastic phenotype was confirmed by treatment with ascorbic acid (50 g/ml), resulting in positive staining for alkaline phosphatase expression (data not shown). For all experiments passages 4 -6 were used, and cells were in a proliferative, nondifferentiated stage of growth.
OFF. All fluid flow experiments were performed under sterile conditions. Primary calvarial osteoblasts from WT and BERKO neonates were plated at 2,500/cm 2 onto glass slides coated with rat type I collagen and grown to 80% confluence. Twenty-four hours before flow, cells were cultured in serum-free medium (phenol red-free DMEM ϩ 0% FCS ϩ 4 mM L-glutamine ϩ 1% penicillin-streptomycin) with ICI-182 780 (10 Ϫ6 M), a pure ER antagonist (Sigma Aldrich, St. Louis, MO), when appropriate. On the day of flow, slides were maintained in static culture or loaded individually into parallel plate flow chambers (17) containing E 2-free or E2-supplemented (10 Ϫ7 M) flow medium. Chambers were connected in series to rigid-walled tubing and a Hamilton glass syringe and plunger. The plunger was driven by a custom-built oscillatory loading device, which produced fluid-flow shear stress (15 dyn/cm 2 , 1 Hz). Depending on the outcome measurement, varying flow periods were used. For p-ERK analysis, 30-min flows were performed. For PGE 2 release and COX-2 expression, 4-h flows were performed, followed by a 1-h postflow incubation. For ER␣ nuclear translocation, 1-h flows were performed. For ERE luciferase activity, 12-h flows were performed.
Immunoblot analysis. For immunoblot analysis, cells were collected in SDS-PAGE sample buffer, and protein concentration was determined using an amido black assay (45) . Equal protein (20 g) was separated by SDS-PAGE and transferred to nitrocellulose for immunoblotting. The following primary antibodies were used: rabbit polyclonal anti-ERK1 and -2 (Santa Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal anti-phospho-ERK (Santa Cruz Biotechnology), rabbit polyclonal anti-COX-2 (Cayman Chemical, Ann Arbor, MI), mouse monoclonal anti-actin (Sigma-Aldrich, St. Louis, MO), and mouse monoclonal anti-vinculin (Sigma-Aldrich). Appropriate anti-mouse or anti-rabbit horseradish peroxidase-conjugated secondary antibodies (Jackson ImmunoResearch Laboratories, West Grove, PA) were used. Horseradish peroxidase chemiluminescence was detected using a Fujifilm LAS-3000 image detection system (Fujifilm, Tokyo, Japan), and densitometric analysis was performed using Fujifilm MultiGauge (version 2) densitometric analysis software (Fujifilm). Actin or vinculin expression was used to normalize gene expression. A minimum of three samples per experimental group was quantified.
PGE2 release. For assessment of prostaglandin release in response to fluid shear stress, cells were subjected to either static conditions or OFF for 4 h. After flow, slides were overlaid with 1 ml pf flow medium and placed in the incubator for 1 h. After 1 h, the medium was collected and assessed for PGE2 concentration using an enzyme immunoassay per the manufacturer's instructions (Amersham Biosciences, Piscataway, NJ). Results were normalized to total cellular protein, as determined by an amido black assay. A minimum of four samples per experimental group was quantified.
Immunofluorescence analysis. WT and BERKO primary calvarial cells were subjected to static conditions or OFF for 1 h, and cells were fixed in cold 4% paraformaldehyde and permeabilized in 0.2% Triton in PBS. A primary antibody against ER␣ (Affinity Bioreagents, Golden, CO) and a FITC-conjugated secondary antibody (Jackson ImmunoResearch Laboratories) were used to visualize ER␣, and DAPI stain (Sigma Chemical, St. Louis, MO) was used to visualize nuclei. Images were captured using a SPOT RT digital camera (Diagnostic Instruments) attached to an Optiphot-2 Nikon epifluorescent microscope with a PlanApo ϫ40 Nikon objective (Nikon, Tokyo, Japan). At least three separate flow experiments were performed for each group, and ϳ10 fields per experiment (slide) were captured. ER␣ expression in WT and BERKO cells was quantified by digital image analysis (Image J; National Institutes of Health) using a threshold technique that captured the number of pixels representing fluorescing protein with each cell.
ERE luciferase reporter. An ERE luciferase reporter plasmid (0.5 g; Panomics) together with an internal control thymidine kinasedriven Renilla luciferase vector plasmid (pRL-TK, 0.5 g; kindly provided by Dr. B. Paul Herring) were cotransfected into WT and BERKO cells. Cells were plated onto glass slides at 50% confluence. The following day, cells were incubated with a total of 1 g of plasmid DNA and 2 l of FuGENE 6 transfection reagent (Roche Diagnostics) in 100 l of phenol red-free, additive-free DMEM (Gibco-Invitrogen). At 48 h posttransfection, cells were subjected to either static conditions or OFF for 12 h. We chose the 12-h time point because 12-h E 2 treatment was shown to induce a detectable increase (ϳ2.5-fold) in relative luciferase activity (firefly/Renilla) in WT cells overexpressing ER␣ (data not shown). After flow, cell lysates were collected. Reporter gene firefly luciferase activities were normalized to internal control Renilla luciferase activities using a Dual Luciferase Reporter Assay System (Promega, Madison, WI) according to the manufacturer's instructions. Data are presented as normalized relative light units. A minimum of three samples per experimental group were analyzed.
Data analysis. Differences were tested for significance using a three-factor ANOVA, with genotype, OFF, and E 2 treatment serving as main factors. Statistical significance was assumed for P Ͻ 0.05. Data are presented as means Ϯ SE.
RESULTS

BERKO calvarial cells exhibit reduced OFF-induced ERK phosphorylation, which is restored by E 2 treatment.
To determine the role of ER␤ in mechanical signaling in osteoblasts, primary calvarial cells were subjected to 30 min of OFF in the absence and presence of E 2 . Phosphorylation of ERK, a wellknown reaction to fluid flow, was determined. In the absence of E 2 , WT cells (WT ϩ VEH) subjected to OFF exhibited an approximately fourfold significant increase in ERK phosphorylation normalized by ERK compared with static controls (Fig. 1) . Under the same conditions, BERKO cells exhibited an increase of approximately twofold, only half of that observed in WT ϩ VEH cells. The absolute value of p-ERK/ERK in BERKO ϩ VEH exposed to OFF was approximately twofold lower than that observed in WT ϩ VEH flowed cells. Interestingly, in the presence of E 2 , flow-induced ERK phosphorylation was restored to near-control levels in BERKO cells, although the difference between groups did not reach significance.
Flow-induced COX-2 upregulation in BERKO cells in the absence of E 2 is attenuated but restored in the presence of E 2 .
Upregulation of COX-2 protein, the rate-limiting enzyme in the production of PGE 2 and an important mediator of in vivo load-induced bone formation (16) , was determined by Western blot analysis. Primary calvarial cells were subjected to 4 h of OFF in the absence and presence of E 2 . Basal COX-2 expression levels in WT cells were ϳ1.7-fold that of BERKO cells regardless of treatment with E 2 (Fig. 2) . COX-2 expression levels were ϳ2.3-fold greater in WT ϩ VEH cells subjected to OFF, a significant increase compared with static controls (Fig.  2B) . In BERKO ϩ VEH cells subjected to OFF, no significant increase in COX-2 expression was detected compared with BERKO ϩ VEH cells kept in static conditions. However, in the presence of E 2 (BERKO ϩ E 2 ), OFF resulted in a significant, 5.9-fold increase in COX-2 expression (Fig. 2B) .
OFF-induced PGE 2 release is greatest in BERKO cells in the presence of E 2 . PGE 2 is an important factor in load-induced bone formation. Therefore, we analyzed PGE 2 release in WT and BERKO cells in response to OFF. To assess ligandindependent and ligand-dependent effects of ER␤ in PGE 2 release, WT and BERKO cells were subjected to 4 h of OFF in the absence and presence of E 2 , and the amount of soluble PGE 2 released 1 h postflow was determined. PGE 2 values for WT ϩ VEH and WT ϩ E 2 cells subjected to OFF was ϳ3.5-fold and ϳ3.1-fold that of static controls, respectively, with absolute values of 24.9 and 29.2 ng/mg of protein (Fig. 3) . BERKO ϩ VEH and BERKO ϩ E 2 cells exhibited a ϳ5.6-fold and ϳ5.0-fold increase, respectively, in PGE 2 in response to OFF; however, total PGE 2 released was significantly greater in BERKO ϩ E2 cells subjected to OFF (47.4 ng/mg protein) when compared with all other groups, both static and OFF. That WT and BERKO cells subjected to OFF exhibit similar levels of PGE 2 in the absence of E 2 suggests that ER␤ has no ligand-independent effect on flow-induced PGE 2 release. Conversely, the robust PGE 2 release in BERKO ϩ E 2 cells subjected to OFF indicates that ligand-dependent signaling via ER␤ normally suppresses flow-induced PGE 2 release in osteoblasts.
BERKO osteoblasts exhibit greater ER␣ expression and enhanced cytoplasmic and nuclear localization. Activation of ERs typically involves receptor translocation to the nucleus, where it binds to the ERE, activating ERE-driven gene transcription. Thus, we next determined the role of ER␤ in ER␣ cellular localization in response to OFF. WT and BERKO calvarial cells were exposed to 1 h of OFF in the absence and presence of E 2 , fixed, and stained for ER␣ and DAPI. By immunofluorescence, we observed that in WT cells exposed to static conditions in the absence of E 2 (WT ϩ VEH), ER␣ was localized primarily in the nucleus, with punctate cell-cell junction and cytoplasmic staining also observed (Fig. 4A) . One hour of OFF appeared to slightly enhance nuclear staining in WT ϩ VEH cells with less membrane staining, indicating a possible ER␣ translocation from cell-cell junctions to the nucleus (Fig. 4B ). E 2 treatment also appeared to increase nuclear staining, whereas the combination of OFF and E 2 did not further enhance ER␣ nuclear localization. In BERKO ϩ VEH cells exposed to static conditions, there was robust cytoplasmic and nuclear ER␣ staining compared with control cells (Fig. 4C) . Both OFF and E 2 appeared to similarly enhance intracellular ER␣ staining, with very little additional enhancement in BERKO cells exposed to the combination of OFF and E 2 (Fig. 4, C and D) . These data suggest that ER␤ may normally help localize ER␣ to the cell membrane, and in the absence of ER␤ there is cytoplasmic and nuclear translocation.
Basal and flow-induced ER transcriptional activity increased in BERKO osteoblasts in the presence or absence of ligand. To determine whether enhanced ER␣ intracellular and nuclear localization observed in BERKO cells translates into changes in transcriptional activity, WT and BERKO cells were cotransfected with an ERE-driven luciferase reporter construct and exposed to static conditions or 12 h of OFF in the absence and presence of E 2 . A small and insignificant increase in relative luciferase activity was observed in both WT and BERKO cells in the absence of E 2 (Fig. 5) . Interestingly, ERE luciferase activity in BERKO cells under both static and flow conditions was significantly greater than activity observed in control cells (P Ͻ 0.05, P Ͻ 0.01). E 2 treatment also resulted in a small and insignificant increase in luciferase activity in WT cells, but the combination of E 2 and OFF did not further increase activity (Fig. 5 ). E 2 treatment alone did not result in increased activity in BERKO cells; however, OFF did lead to significantly greater activity in BERKO ϩ E 2 cells compared with BERKO ϩ E 2 static controls. Again, both basal and OFF-induced luciferase activities were significantly increased in BERKO cells compared with controls in the presence of E 2 . Thus, the increased ER␣ localization to the cytoplasm and nucleus in BERKO cells corresponds with greater ERE activity observed in these cells, suggesting that ER␤ normally inhibits ER␣ transcriptional activity.
DISCUSSION
ER␤ plays a significant role in regulating important cellular mechanotransduction events of ERK phosphorylation, COX-2 upregulation, and PGE 2 release. We show that BERKO cells exhibit higher levels of ER␣ expression, an increase in ER transcriptional activity, and flow-and ligand-induced PGE 2 release.
Important mechanical signaling events in osteoblasts include activation of the MAPK pathway, an increase in COX-2 expression, and release of prostaglandins. Phosphorylation of ERK, a member of the MAPK family, peaks within the first 15 min after application of fluid flow shear stress in osteoblasts and endothelial cells (50, 53) and, as mentioned previously, is known to be important in cell proliferation, differentiation, and apoptosis. COX-2 is an important enzyme in the conversion of arachidonic acid into prostaglandins. In vitro, COX-2 mRNA and protein levels increase in response to fluid flow shear stress, making it an important indicator of mechanotransduction in osteoblasts (3, 39) . Prostaglandins are lipid mediators that are involved in the inflammatory response (38) . PGE 2 is the most abundant prostaglandin in the human body, with known anabolic effects in bone (49) . Significant increases in cellular production of PGE 2 in response to fluid flow shear stress have been shown to affect TGF␤ release, an important mediator of bone remodeling (24, 40) .
Recent data suggest that ER␣ and ER␤ can regulate mechanical signaling in bone, and ER␤ itself or signaling via ER␤ may normally oppose ER␣ in osteoblasts. Adult female BERKO mice have increased trabecular bone volume (46), significantly higher cortical bone content and periosteal circumference (23) , and enhanced load-induced bone formation (43) , indicating that ER␤ negatively regulates radial bone apposition during growth and in response to mechanical stimuli.
Our results indicate that ER␤ can regulate signaling pathways shown to be important in mechanical signaling in osteoblasts, including ERK phosphorylation, COX-2 expression, PGE 2 release, and ER␣ localization. Of these, only PGE 2 release appears to be affected by ligand-dependent ER␤ signaling. BERKO cells exhibit reduced OFF-induced ERK phosphorylation compared with WT cells in the absence of E 2 . Because ERK phosphorylation is involved in increased cell proliferation and differentiation (52) , this result suggests that ER␤ may be important for osteoblast proliferation in response to mechanical stimuli in the absence of ligand. This hypothesis is in contrast to previously published data showing that primary osteoblasts isolated from female BERKO mice exhibit greater proliferation rates in response to mechanical strain compared with WT cells in vitro (125 vs. 61%) (29) , suggesting that ER␤ is antiproliferative. In fact, other studies have shown that ER␤ can directly inhibit ER␣-mediated cyclin D1 gene activation, a key regulator for entry into the proliferative stage of the cell cycle (31). Although we did not assess flow-induced proliferation in this study, we did not observe significant differences in basal growth rate in BERKO cells by both manual counts and a biochemical assay (data not shown). The means of mechanical stimulation used in the two studies (strain vs. OFF) could explain these conflicting data. This result is not in agreement with in vivo data in female BERKO mice. That is, if ERK phosphorylation played a direct role in the enhanced loadinduced bone formation observed in female BERKO mice, then p-ERK levels would be greatest in BERKO ϩ E2 cells. The fact that p-ERK levels appear to be similar in BERKO ϩ E2 cells compared with WT ϩ E 2 suggests that mechanisms other than ERK phosphorylation are important in enhanced load-induced bone formation in BERKO mice.
COX-2 is an important enzyme in the conversion of arachidonic acid into prostaglandins (7, 11, 39) . In vitro, COX-2 mRNA and protein levels increase in response to fluid flow shear stress (3). In addition, selective inhibition of COX-2 effectively blocks flow-induced PGE 2 release in vitro (9) and load-induced bone formation in vivo (10) . That there is an increase in flow-induced COX-2 expression in WT but not BERKO cells in the absence of E 2 suggests that ER␤ is normally permissive of flow-induced COX-2 expression in a ligand-independent manner. Furthermore, the concomitant increase in both COX-2 protein and PGE 2 release in WT but not BERKO cells suggests that sustained COX-2 synthesis is not necessary for PGE 2 release in BERKO cells (Figs. 2 and 3) . We have not ruled out the possibility that COX-2 expression was upregulated at an earlier time point and then decreased over the course of the 4-h flow, which could alternatively account for the increased PGE 2 release. Thus, the COX-2 and PGE 2 data taken together suggest that, in the absence of ligand, the magnitude of the COX-2 and PGE 2 responses is not tightly coupled in BERKO cells. Further studies are needed to determine whether ER␤ regulates the relationship between COX-2 expression and PGE 2 release.
BERKO ϩ E 2 cells showed significantly greater PGE 2 release when compared with all other experimental groups. PGE 2 is a known anabolic agent whose increased cellular production may result in greater osteogenic activity. In vivo administration of PGE 2 to young rats results in increased trabecular bone volume and greater proliferation and differentiation of progenitors in the marrow (51) . Treatment of rat calvarial osteoblasts with PGE 2 results in a dose-dependent increase in the osteoblast differentiation markers, alkaline phosphatase activity, and mineralized bone nodule formation (22) . Enhanced PGE 2 release observed in BERKO cells may provide a mechanism for enhanced load-induced bone formation observed in female BERKO mice.
ERs are localized mainly in the cellular membrane and nucleus, with some cytoplasmic localization (32) . Upon ligand binding, ERs form homo-or heterodimers and translocate to the nucleus, where they affect gene transcription. We observed significantly greater ER␣ expression in BERKO cells, an observation supported by data showing that ER␤ causes a significant increase in ligand-dependent ER␣ degradation in T47D human breast carcinoma cells within 3 h of E 2 treatment (33). We also observed greater cell-cell junction localization of ER␣ in WT cells, suggesting that ER␤ may normally affect the subcellular localization of ER␣. The mechanism by which subpopulations of estrogen receptors localize to the membrane is unclear, and further studies are needed to address the possibility that ER␤ is involved in membrane localization of ER␣.
The overall increase in ERE luciferase reporter activity in BERKO cells supports the observed increased nuclear ER␣ localization (Fig. 5) . Additionally, these studies confirm significantly increased ER transcriptional activity in response to flow in BERKO cells, a phenomenon we did not observe in WT cells. These data are in agreement with studies showing that ER␤ can negatively regulate estrogen-mediated transcriptional activity in bone. Microarray analysis of estrogen-mediated gene expression in the humerus of ovariectomized BERKO mice was shown to be 85% higher compared with WT controls (30) . Animal data are supported by studies showing a negative regulatory role for ER␤ in human bone metabolism. Japanese postmenopausal women who harbored one or two alleles of a specific ER␤ gene polymorphism had significantly higher lumbar bone mineral density compared with control subjects not possessing the polymorphism (34) . The mechanism of action on bone mineral density is unclear, but the Ogawa et al. (35) have suggested that the polymorphism may lead to changes in ER␤ protein function, which could affect the action of E 2 on bone. Taken together, these data suggest that ER␤ normally acts to negatively regulate ER␣ transcriptional activity. It is clear that ER␣ plays an important role in bones' response to mechanical loading. In addition, ER␣ appears to also be required for Wnt/␤-catenin signaling (2). Galea et al. (18) showed that flow activated nuclear accumulation of ␤-catenin and activated the TCF/LEF promoter in ROS 17/2.8 cells. This response was inhibited by treatment with the ER modulator ICI-182,780 and the GSK-3␤ inhibitor lithium chloride. In addition, this response was not observed in ER␣ Ϫ/Ϫ mice, suggesting that ER␣ is required for Wnt/␤-catenin signaling in response to mechanical loading. More recently, the same group showed that both strain and estrogen work through ER␤ to downregulate Sost expression (18) , a gene that inhibits Wnt signaling and attenuates osteoblast bone formation. Thus, Wnt signaling can be regulated by both ER␣ and ER␤. If the loss of ER␤ results in upregulation of ER␣, then it may also enhance Wnt/␤-catenin signaling, providing another mechanism by which BERKO mice exhibit enhanced mechanical adaptation.
One interesting observation that should be addressed is the fact that E 2 treatment did not activate ERE activity. One possible explanation for this is that endogenous ER expression in osteoblasts is low (15) , potentially resulting in relatively low ERE activity levels. In a separate experiment, we showed that ERE activity increased in a time-dependent manner only after cells were transfected with ERs (data not shown). This response increased significantly after 12 h of treatment. Keeping in mind that BERKO cells appear to have greater ER␣ expression, it is curious they did not exhibit increased ERE activity with E 2 treatment when they clearly exhibited greater basal ERE activity relative to WT cells. One possible explanation for this observation is that the effect of E 2 and OFF may require different treatment periods before significant changes in ERE activity transpire. Zaman et al. (56) showed that, in osteocytes, strain and estrogen resulted in transient changes in ER␣ mRNA levels; however, the effects of strain were larger and occurred earlier than those associated with estrogen treatment. They also showed that 36 h of E 2 treatment, at similar doses used in the current study, resulted in a significant increase in ERE-CAT reporter gene activity in ROS.SMER no. 14 cells, with less of an effect observed at 18 h (55), suggesting that our 12-h treatment period may have been too short to allow significant accumulation of the ERE luciferase product. The aim of this work was to determine the mechanisms by which ER␤ regulates mechanical signaling in bone. We observed a suppression of OFF-induced increases in BERKO cells in the absence of ligand of both ERK and COX-2, two molecules associated with load-induced increases in bone formation, suggesting that a different mechanism may be at play. Increased expression and transcriptional activity of ER␣ in BERKO cells is perhaps the means by which enhancement of load-induced bone formation occurs. Additionally, we observed no difference in the ability of BERKO cells to release PGE 2 in response to flow in the absence of E 2 , and in fact, we observed a synergistic effect of flow and E 2 . Considering the importance of prostaglandins in load-induced bone formation, this result could explain increased bone formation observed in BERKO mice. Both ER␣ and ER␤ can regulate mechanical signaling in bone and influence bone adaptation, and in targeting ERs (e.g., inhibiting ER␤), it may represent an effective approach for prevention and treatment of age-related bone loss.
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